Macrophages and their relevance in Human Immunodeficiency Virus Type I infection

Retrovirology

Volumn 9, Issue , 2012, Pages

  Koppensteiner, Herwig ^a   Brack Werner, Ruth ^a   Schindler, Michael ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DISEASE; BRAIN INFECTION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE TRANSMISSION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; INFECTION CONTROL; INFECTION PREVENTION; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MACROPHAGE; NEUROPATHOLOGY; REVIEW; VAGINA MUCOSA; VIREMIA; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS LOAD; VIRUS REPLICATION; VIRUS VIRULENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84866885992     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-82     Document Type: Review

References (146)

1. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986, 47:333-348. 10.1016/0092-8674(86)90590-8, 3094962.
2. Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engleman EG. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature 1986, 323:725-728. 10.1038/323725a0, 3095663.
3. Koenig S, Gendelman HE, Orenstein JM. Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986, 233:1089-1093. 10.1126/science.3016903, 3016903.
4. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964. 10.1038/nri1733, 16322748.
5. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-737. 10.1038/nri3073, 3422549, 21997792.
6. Ackerman AL, Cresswell P. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat Immunol 2004, 5:678-684.
7. Bellingan GJ, Caldwell H, Howie SE, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol 1996, 157:2577-2585.
8. Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. Glia 1993, 7:19-24. 10.1002/glia.440070106, 7678581.
9. Murphy J, Summer R, Wilson AA, Kotton DN, Fine A. The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol 2008, 38:380-385. 10.1165/rcmb.2007-0224RC, 2274942, 18192503.
10. Melnicoff MJ, Horan PK, Breslin EW, Morahan PS. Maintenance of peritoneal macrophages in the steady state. J Leukoc Biol 1988, 44:367-375.
11. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog 2011, 7:e1002286. 10.1371/journal.ppat.1002286, 3188520, 22007152.
12. Soulas C, Conerly C, Kim WK, Burdo TH, Alvarez X, Lackner AA, Williams KC. Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation. Am J Pathol 2011, 178:2121-2135. 10.1016/j.ajpath.2011.01.023, 3081227, 21514427.
13. Gras G, Kaul M. Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. Retrovirology 2010, 7:30. 10.1186/1742-4690-7-30, 2864195, 20374632.
14. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A. Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 1995, 9:859-866. 10.1097/00002030-199508000-00005, 7576319.
15. Dorosko SM, Connor RI. Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes. J Virol 2010, 84:10533-10542. 10.1128/JVI.01263-10, 2950585, 20702626.
16. Yagi Y, Watanabe E, Watari E, Shinya E, Satomi M, Takeshita T, Takahashi H. Inhibition of DC-SIGN-mediated transmission of human immunodeficiency virus type 1 by Toll-like receptor 3 signalling in breast milk macrophages. Immunology 2010, 130:597-607. 10.1111/j.1365-2567.2010.03264.x, 2913270, 20406303.
17. Stevenson M. HIV-1 pathogenesis. Nat Med 2003, 9:853-860. 10.1038/nm0703-853, 12835705.
18. Bergamaschi A, Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010, 7:31. 10.1186/1742-4690-7-31, 2868797, 20374633.
19. Duncan CJ, Sattentau QJ. Viral determinants of HIV-1 macrophage tropism. Viruses 2011, 3:2255-2279. 10.3390/v3112255, 3230851, 22163344.
20. Gobeil LA, Lodge R, Tremblay MJ. Differential HIV-1 endocytosis and susceptibility to virus infection in human macrophages correlate with the cell activation status. J Virol 2012, 86(19):10399-10407. 10.1128/JVI.01051-12, 22787228.
21. Shen R, Richter HE, Smith PD. Early HIV-1 target cells in human vaginal and ectocervical mucosa. Am J Reprod Immunol 2011, 65:261-267. 10.1111/j.1600-0897.2010.00939.x, 3077123, 21118402.
22. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-219. 10.1126/science.3014648, 3014648.
23. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996, 271:1582-1586. 10.1126/science.271.5255.1582, 8599114.
24. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M. Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 2007, 3:1281-1290. 2323301, 17907802.
25. Igarashi T, Brown CR, Endo Y, Buckler-White A, Plishka R, Bischofberger N, Hirsch V, Martin MA. Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc Natl Acad Sci U S A 2001, 98:658-663. 10.1073/pnas.98.2.658, 14644, 11136236.
26. Reynoso R, Wieser M, Ojeda D, Bonisch M, Kuhnel H, Bolcic F, Quendler H, Grillari J, Grillari-Voglauer R, Quarleri J. HIV-1 induces telomerase activity in monocyte-derived macrophages - safeguarding one of its reservoirs?. J Virol 2012, 86(19):10327-10337. 10.1128/JVI.01495-12, 22787205.
27. Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078. 10.1056/NEJM199704103361507, 9091805.
28. Greenhead P, Hayes P, Watts PS, Laing KG, Griffin GE, Shattock RJ. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000, 74:5577-5586. 10.1128/JVI.74.12.5577-5586.2000, 112045, 10823865.
29. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, Mayer K, Wright PF, Kappes JC, Ochsenbauer C, Wira CR. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 2010, 5:e11366. 10.1371/journal.pone.0011366, 2894072, 20614007.
30. Cicala C, Arthos J, Fauci AS. HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV. J Transl Med 2011, 9(Suppl 1):S2. 3105502, 21284901.
31. Bakri Y, Schiffer C, Zennou V, Charneau P, Kahn E, Benjouad A, Gluckman JC, Canque B. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J Immunol 2001, 166:3780-3788.
32. Coleman CM, Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009, 6:51. 10.1186/1742-4690-6-51, 2697150, 19486514.
33. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474:654-657. 10.1038/nature10117, 21613998.
34. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597. 10.1016/S0092-8674(00)80694-7, 10721995.
35. Pohlmann S, Soilleux EJ, Baribaud F, Leslie GJ, Morris LS, Trowsdale J, Lee B, Coleman N, Doms RW. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A 2001, 98:2670-2675. 10.1073/pnas.051631398, 30196, 11226297.
36. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004, 10:282-289. 10.1038/nm992, 14770175.
37. Mwimanzi P, Hasan Z, Hassan R, Suzu S, Takiguchi M, Ueno T. Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages. Retrovirology 2011, 8:50. 10.1186/1742-4690-8-50, 3131245, 21696586.
38. Schwartz O, Marechal V, Le Gall S, Lemonnier F, Heard JM. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996, 2:338-342. 10.1038/nm0396-338, 8612235.
39. Schindler M, Munch J, Kirchhoff F. Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism. J Virol 2005, 79:5489-5498. 10.1128/JVI.79.9.5489-5498.2005, 1082752, 15827163.
40. Brown A, Gartner S, Kawano T, Benoit N, Cheng-Mayer C. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus. J Leukoc Biol 2005, 78:675-685. 10.1189/jlb.0505237, 16000390.
41. Schindler M, Rajan D, Banning C, Wimmer P, Koppensteiner H, Iwanski A, Specht A, Sauter D, Dobner T, Kirchhoff F. Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue. Retrovirology 2010, 7:1. 10.1186/1742-4690-7-1, 2823648, 20078884.
42. Shen R, Richter HE, Clements RH, Novak L, Huff K, Bimczok D, Sankaran-Walters S, Dandekar S, Clapham PR, Smythies LE, Smith PD. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol 2009, 83:3258-3267. 10.1128/JVI.01796-08, 2655566, 19153236.
43. Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M. HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 1999, 5:997-1003. 10.1038/12433, 10470075.
44. Swingler S, Brichacek B, Jacque JM, Ulich C, Zhou J, Stevenson M. HIV-1 Nef intersects the macrophage CD40L signalling pathway to promote resting-cell infection. Nature 2003, 424:213-219. 10.1038/nature01749, 12853962.
45. Herbein G, Gras G, Khan KA, Abbas W. Macrophage signaling in HIV-1 infection. Retrovirology 2010, 7:34. 10.1186/1742-4690-7-34, 2865443, 20380698.
46. Herbein G, Varin A. The macrophage in HIV-1 infection: from activation to deactivation?. Retrovirology 2010, 7:33. 10.1186/1742-4690-7-33, 2859752, 20380696.
47. Waki K, Freed EO. Macrophages and Cell-Cell Spread of HIV-1. Viruses 2010, 2:1603-1620. 10.3390/v2081603, 3088113,3088113, 21552427.
48. Groot F, Welsch S, Sattentau QJ. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 2008, 111:4660-4663. 10.1182/blood-2007-12-130070, 18296630.
49. Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, Ott DE, Freed EO. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog 2008, 4:e1000015. 10.1371/journal.ppat.1000015, 2267008, 18369466.
50. Jolly C, Sattentau QJ. Retroviral spread by induction of virological synapses. Traffic 2004, 5:643-650. 10.1111/j.1600-0854.2004.00209.x, 15296489.
51. Epple HJ, Zeitz M. HIV infection and the intestinal mucosal barrier. Ann N Y Acad Sci 2012, 1258:19-24. 10.1111/j.1749-6632.2012.06512.x, 22731711.
52. Brenchley JM, Douek DC. The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008, 3:356-361. 10.1097/COH.0b013e3282f9ae9c, 2789390, 19372990.
53. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
54. Porcheray F, Samah B, Leone C, Dereuddre-Bosquet N, Gras G. Macrophage activation and human immunodeficiency virus infection: HIV replication directs macrophages towards a pro-inflammatory phenotype while previous activation modulates macrophage susceptibility to infection and viral production. Virology 2006, 349:112-120. 10.1016/j.virol.2006.02.031, 16564558.
55. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 2001, 193:905-915. 10.1084/jem.193.8.905, 2193403, 11304551.
56. Guillemin GJ, Brew BJ. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004, 75:388-397.
57. Crowe S, Zhu T, Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol 2003, 74:635-641. 10.1189/jlb.0503204, 12960232.
58. Thompson KA, Varrone JJ, Jankovic-Karasoulos T, Wesselingh SL, McLean CA. Cell-specific temporal infection of the brain in a simian immunodeficiency virus model of human immunodeficiency virus encephalitis. J Neurovirol 2009, 15:300-311. 10.1080/13550280903030125, 19593698.
59. Thompson KA, Cherry CL, Bell JE, McLean CA. Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals. Am J Pathol 2011, 179:1623-1629. 10.1016/j.ajpath.2011.06.039, 3181362, 21871429.
60. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239:290-292. 10.1126/science.3276004, 3276004.
61. Nath A, Clements JE. Eradication of HIV from the brain: reasons for pause. AIDS 2011, 25:577-580. 10.1097/QAD.0b013e3283437d2f, 21160414.
62. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 2010, 10:11-23. 10.1038/nri2674, 3119211, 20010788.
63. Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu Rev Pathol 2011, 6:223-248. 10.1146/annurev-pathol-011110-130254, 21034222.
64. Abela IA, Berlinger L, Schanz M, Reynell L, Gunthard HF, Rusert P, Trkola A. Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog 2012, 8:e1002634. 10.1371/journal.ppat.1002634, 3320602, 22496655.
65. Koppensteiner H, Banning C, Schneider C, Hohenberg H, Schindler M. Macrophage internal HIV-1 is protected from neutralizing antibodies. J Virol 2012, 86:2826-2836. 10.1128/JVI.05915-11, 3302290, 22205742.
66. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 1988, 62:2578-2586. 253687, 3260631.
67. Benaroch P, Billard E, Gaudin R, Schindler M, Jouve M. HIV-1 assembly in macrophages. Retrovirology 2010, 7:29. 10.1186/1742-4690-7-29, 2861634, 20374631.
68. Carter CA, Ehrlich LS. Cell biology of HIV-1 infection of macrophages. Annu Rev Microbiol 2008, 62:425-443. 10.1146/annurev.micro.62.081307.162758, 18785842.
69. Sharova N, Swingler C, Sharkey M, Stevenson M. Macrophages archive HIV-1 virions for dissemination in trans. EMBO J 2005, 24:2481-2489. 10.1038/sj.emboj.7600707, 1173148, 15920469.
70. Chu H, Wang JJ, Qi M, Yoon JJ, Wen X, Chen X, Ding L, Spearman P. The intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules. PLoS One 2012, 7:e35297. 10.1371/journal.pone.0035297, 3342280, 22567100.
71. Kadiu I, Narayanasamy P, Dash PK, Zhang W, Gendelman HE. Biochemical and Biologic Characterization of Exosomes and Microvesicles as Facilitators of HIV-1 Infection in Macrophages. J Immunol 2012, 189(2):744-754. 10.4049/jimmunol.1102244, 22711894.
72. Kamp C. Understanding the HIV coreceptor switch from a dynamical perspective. BMC Evol Biol 2009, 9:274. 10.1186/1471-2148-9-274, 2797020, 19948048.
73. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997, 185:621-628. 10.1084/jem.185.4.621, 2196142, 9034141.
74. Gonzalez-Perez MP, O'Connell O, Lin R, Sullivan WM, Bell J, Simmonds P, Clapham PR. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. Retrovirology 2012, 9:20. 10.1186/1742-4690-9-20, 3362761, 22420378.
75. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276:1857-1861. 10.1126/science.276.5320.1857, 9188531.
76. Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, Sugimoto C, Alvarez X, Kuroda MJ, Williams KC. Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 2010, 6:e1000842. 10.1371/journal.ppat.1000842, 2855320, 20419144.
77. Hasegawa A, Liu H, Ling B, Borda JT, Alvarez X, Sugimoto C, Vinet-Oliphant H, Kim WK, Williams KC, Ribeiro RM, et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 2009, 114:2917-2925. 10.1182/blood-2009-02-204263, 2756202, 19383966.
78. Kuroda MJ. Macrophages: do they impact AIDS progression more than CD4 T cells?. J Leukoc Biol 2010, 87:569-573. 10.1189/jlb.0909626, 20053708.
79. Cassol E, Cassetta L, Rizzi C, Alfano M, Poli G. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol 2009, 182:6237-6246. 10.4049/jimmunol.0803447, 19414777.
80. Cassol E, Cassetta L, Alfano M, Poli G. Macrophage polarization and HIV-1 infection. J Leukoc Biol 2010, 87:599-608. 10.1189/jlb.1009673, 20042468.
81. Cassetta L, Cassol E, Poli G. Macrophage polarization in health and disease. Scientific World Journal 2011, 11:2391-2402. 3236674, 22194670.
82. Chihara T, Hashimoto M, Osman A, Hiyoshi-Yoshidomi Y, Suzu I, Chutiwitoonchai N, Hiyoshi M, Okada S, Suzu S. HIV-1 proteins preferentially activate anti-inflammatory M2-type macrophages. J Immunol 2012, 188:3620-3627. 10.4049/jimmunol.1101593, 22407921.
83. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000, 18:665-708. 10.1146/annurev.immunol.18.1.665, 10837072.
84. Zhang ZQ, Notermans DW, Sedgewick G, Cavert W, Wietgrefe S, Zupancic M, Gebhard K, Henry K, Boies L, Chen Z, et al. Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc Natl Acad Sci U S A 1998, 95:1154-1159. 10.1073/pnas.95.3.1154, 18704, 9448301.
85. Wein LM, D'Amato RM, Perelson AS. Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. J Theor Biol 1998, 192:81-98. 10.1006/jtbi.1997.0622, 9628841.
86. Chun TW, Fauci AS. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci U S A 1999, 96:10958-10961. 10.1073/pnas.96.20.10958, 34225, 10500107.
87. Le Douce V, Herbein G, Rohr O, Schwartz C. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 2010, 7:32. 10.1186/1742-4690-7-32, 2873506, 20380694.
88. Carter CC, Onafuwa-Nuga A, McNamara LA, Riddell J, Bixby D, Savona MR, Collins KL. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010, 16:446-451. 10.1038/nm.2109, 2892382, 20208541.
89. Coiras M, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat Rev Microbiol 2009, 7:798-812. 10.1038/nrmicro2223, 19834480.
90. Best BM, Letendre SL, Koopmans P, Rossi SS, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, et al. Low cerebrospinal fluid concentrations of the nucleotide HIV reverse transcriptase inhibitor, tenofovir. J Acquir Immune Defic Syndr 2012, 59:376-381. 10.1097/QAI.0b013e318247ec54, 22217676.
91. Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008, 6:388-400. 10.2174/157016208785861195, 2683678, 18855649.
92. Orenstein JM, Bhat N, Yoder C, Fox C, Polis MA, Metcalf JA, Kovacs JA, Falloon J, Walker RE, Masur H, et al. Rapid activation of lymph nodes and mononuclear cell HIV expression upon interrupting highly active antiretroviral therapy in patients after prolonged viral suppression. AIDS 2000, 14:1709-1715. 10.1097/00002030-200008180-00004, 10985306.
93. Zalar A, Figueroa MI, Ruibal-Ares B, Bare P, Cahn P, de Bracco MM, Belmonte L. Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART. Antiviral Res 2010, 87:269-271. 10.1016/j.antiviral.2010.05.005, 20471997.
94. Harrold SM, Wang G, McMahon DK, Riddler SA, Mellors JW, Becker JT, Caldararo R, Reinhart TA, Achim CL, Wiley CA. Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy. AIDS Res Hum Retroviruses 2002, 18:427-434. 10.1089/088922202753614191, 11958686.
95. Llewellyn N, Zioni R, Zhu H, Andrus T, Xu Y, Corey L, Zhu T. Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J Leukoc Biol 2006, 80:1118-1126. 10.1189/jlb.0306144, 17056765.
96. Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE. HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis 2010, 37:542-548. 10.1016/j.nbd.2009.12.015, 2840259, 20044002.
97. Perno CF, Newcomb FM, Davis DA, Aquaro S, Humphrey RW, Calio R, Yarchoan R. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J Infect Dis 1998, 178:413-422. 10.1086/515642, 9697721.
98. Srinivas RV, Middlemas D, Flynn P, Fridland A. Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters. Antimicrob Agents Chemother 1998, 42:3157-3162. 106016, 9835508.
99. Jorajuria S, Dereuddre-Bosquet N, Becher F, Martin S, Porcheray F, Garrigues A, Mabondzo A, Benech H, Grassi J, Orlowski S, et al. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages. Antivir Ther 2004, 9:519-528.
100. Bierman WF, Scheffer GL, Schoonderwoerd A, Jansen G, van Agtmael MA, Danner SA, Scheper RJ. Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines. J Antimicrob Chemother 2010, 65:1672-1680. 10.1093/jac/dkq209, 20551216.
101. Yadav A, Collman RG. CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol 2009, 4:430-447. 10.1007/s11481-009-9174-2, 19768553.
102. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799. 10.1212/01.WNL.0000287431.88658.8b, 17914061.
103. Boisse L, Gill MJ, Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 2008, 26:799-819. 10.1016/j.ncl.2008.04.002, 18657727.
104. McArthur JC, Steiner J, Sacktor N, Nath A. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol 2010, 67:699-714.
105. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog 2009, 5:e1000395. 10.1371/journal.ppat.1000395, 2668697, 19390619.
106. Williams KC, Hickey WF. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002, 25:537-562. 10.1146/annurev.neuro.25.112701.142822, 12052920.
107. Williams DW, Eugenin EA, Calderon TM, Berman JW. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis. J Leukoc Biol 2012, 91:401-415. 10.1189/jlb.0811394, 22227964.
108. Eugenin EA, Clements JE, Zink MC, Berman JW. Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci 2011, 31:9456-9465. 10.1523/JNEUROSCI.1460-11.2011, 3132881, 21715610.
109. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005, 111:194-213. 10.1016/j.virusres.2005.04.009, 15885841.
110. Gonzalez-Scarano F, Martin-Garcia J. The neuropathogenesis of AIDS. Nat Rev Immunol 2005, 5:69-81. 10.1038/nri1527, 15630430.
111. Thomas ER, Dunfee RL, Stanton J, Bogdan D, Taylor J, Kunstman K, Bell JE, Wolinsky SM, Gabuzda D. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology 2007, 360:105-119. 10.1016/j.virol.2006.09.036, 1890014, 17084877.
112. Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, et al. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol 2001, 75:10073-10089. 10.1128/JVI.75.21.10073-10089.2001, 114582, 11581376.
113. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 2009, 66:253-258. 10.1002/ana.21697, 19743454.
114. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999, 13:1-22. 10.1097/00002030-199901140-00003, 10207540.
115. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, Vesselingh SL, Purcell DF. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res 2003, 1:463-473. 10.2174/1570162033485122, 15049431.
116. Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008, 20:15-24. 10.1080/09540260701862037, 18240059.
117. Winkler MK, Beveniste EN. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. Glia 1998, 22:171-179. 10.1002/(SICI)1098-1136(199802)22:2<171::AID-GLIA8>3.0.CO;2-A, 9537837.
118. Lee SJ, Hou J, Benveniste EN. Transcriptional regulation of intercellular adhesion molecule-1 in astrocytes involves NF-kappaB and C/EBP isoforms. J Neuroimmunol 1998, 92:196-207. 10.1016/S0165-5728(98)00209-4, 9916895.
119. Meggendorfer M, Rothenaigner I, Tigges B, Vincendeau M, Brack-Werner R. Neurotoxicity of HIV-1 proteins. The Neurology of AIDS 2012, 275-288. Oxford University Press, Oxford, Gendelman H, Grant I, Everall I, Fox H, Gelbard H, Lipton S, Swindells S, 3.
120. Mothobi NZ, Brew BJ. Neurocognitive dysfunction in the highly active antiretroviral therapy era. Curr Opin Infect Dis 2012, 25:4-9. 10.1097/QCO.0b013e32834ef586, 22156897.
121. Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol 2012, 13:214-222. 10.1038/ni.2229, 22344284.
122. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103. 10.1038/nature01709, 12808466.
123. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252. 10.1016/j.chom.2008.03.001, 2474773, 18342597.
124. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
125. Sauter D, Schindler M, Specht A, Landford WN, Munch J, Kim KA, Votteler J, Schubert U, Bibollet-Ruche F, Keele BF, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009, 6:409-421. 10.1016/j.chom.2009.10.004, 2779047, 19917496.
126. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011, 474:658-661. 10.1038/nature10195, 3179858, 21720370.
127. Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, Bloch N, Maudet C, Bertrand M, Gramberg T, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012, 13:223-228.
128. Kim B, Nguyen LA, Daddacha W, Hollenbaugh JA. Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. J Biol Chem 2012, 287:21570-21574. 10.1074/jbc.C112.374843, 22589553.
129. Brandariz-Nunez A, Valle-Casuso JC, White TE, Laguette N, Benkirane M, Brojatsch J, Diaz-Griffero F. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology 2012, 9:49. 10.1186/1742-4690-9-49, 3410799, 22691373.
130. Miyagi E, Andrew AJ, Kao S, Strebel K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A 2009, 106:2868-2873. 10.1073/pnas.0813223106, 2650357, 19196977.
131. Nasr N, Maddocks S, Turville SG, Harman AN, Woolger N, Helbig KJ, Wilkinson J, Bye CR, Wright TK, Rambukwelle D, et al. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 2012, 120(4):778-788. 10.1182/blood-2012-01-407395, 22677126.
132. Lim ES, Wu LI, Malik HS, Emerman M. The function and evolution of the restriction factor viperin in primates was not driven by lentiviruses. Retrovirology 2012, 9:55. 10.1186/1742-4690-9-55, 3414838, 22734835.
133. Bergamaschi A, David A, Le Rouzic E, Nisole S, Barre-Sinoussi F, Pancino G. The CDK inhibitor p21Cip1/WAF1 is induced by FcgammaR activation and restricts the replication of human immunodeficiency virus type 1 and related primate lentiviruses in human macrophages. J Virol 2009, 83:12253-12265. 10.1128/JVI.01395-09, 2786717, 19759136.
134. Zhang J, Scadden DT, Crumpacker CS. Primitive hematopoietic cells resist HIV-1 infection via p21. J Clin Invest 2007, 117:473-481. 10.1172/JCI28971, 1783820, 17273559.
135. Saez-Cirion A, Hamimi C, Bergamaschi A, David A, Versmisse P, Melard A, Boufassa F, Barre-Sinoussi F, Lambotte O, Rouzioux C, Pancino G. Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. Blood 2011, 118:955-964. 10.1182/blood-2010-12-327106, 3148172, 21642597.
136. Van den Bergh R, Florence E, Vlieghe E, Boonefaes T, Grooten J, Houthuys E, Tran HT, Gali Y, De Baetselier P, Vanham G, Raes G. Transcriptome analysis of monocyte-HIV interactions. Retrovirology 2010, 7:53. 10.1186/1742-4690-7-53, 2900222, 20546557.
137. Liu L, Oliveira NM, Cheney KM, Pade C, Dreja H, Bergin AM, Borgdorff V, Beach DH, Bishop CL, Dittmar MT, McKnight A. A whole genome screen for HIV restriction factors. Retrovirology 2011, 8:94. 10.1186/1742-4690-8-94, 3228845, 22082156.
138. Friedrich BM, Murray JL, Li G, Sheng J, Hodge TW, Rubin DH, O'Brien WA, Ferguson MR. A functional role for ADAM10 in human immunodeficiency virus type-1 replication. Retrovirology 2011, 8:32. 10.1186/1742-4690-8-32, 3118345, 21569301.
139. Contreras X, Mzoughi O, Gaston F, Peterlin MB, Bahraoui E. Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages. Retrovirology 2012, 9:37. 10.1186/1742-4690-9-37, 3432598, 22554282.
140. Vincendeau M, Kramer S, Hadian K, Rothenaigner I, Bell J, Hauck SM, Bickel C, Nagel D, Kremmer E, Werner T, et al. Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp). AIDS 2010, 24:2433-2442. 10.1097/QAD.0b013e32833e8758, 20827171.
141. Snoeck J, Fellay J, Bartha I, Douek DC, Telenti A. Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology 2011, 8:87. 10.1186/1742-4690-8-87, 3229471, 22044801.
142. Bol SM, van Remmerden Y, Sietzema JG, Kootstra NA, Schuitemaker H, van't Wout AB. Donor variation in vitro HIV-1 susceptibility of monocyte-derived macrophages. Virology 2009, 390:205-211. 10.1016/j.virol.2009.05.027, 19535121.
143. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, Emerman M. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 2012, 11:194-204. 10.1016/j.chom.2012.01.004, 22284954.
144. Laguette N, Rahm N, Sobhian B, Chable-Bessia C, Munch J, Snoeck J, Sauter D, Switzer WM, Heneine W, Kirchhoff F, et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 2012, 11:205-217. 10.1016/j.chom.2012.01.007, 22305291.
145. Zhang C, de Silva S, Wang JH, Wu L. Co-evolution of primate SAMHD1 and lentivirus Vpx leads to the loss of the vpx gene in HIV-1 ancestor. PLoS One 2012, 7:e37477. 10.1371/journal.pone.0037477, 3345027, 22574228.
146. Coon S, Wang D, Wu L. Polymorphisms of the SAMHD1 Gene Are Not Associated with the Infection and Natural Control of HIV Type 1 in Europeans and African-Americans. AIDS Res Hum Retroviruses 2012, Jun 1, [Epub ahead of print].